News|Articles|December 2, 2004
- Pharmaceutical Technology-12-02-2004
- Volume 28
- Issue 11
Robust CRO Market Is Driving New Merger and Acquisition Activity
Author(s)Jim Miller
The blockage in the new product pipeline may be breaking. CROs report increased demand for late-stage development services in their latest round of earnings reports.
Advertisement
Articles in this issue
almost 21 years ago
In the Spotlight-December 2004almost 21 years ago
Safety Problems Roil Pharma and FDAalmost 21 years ago
December 2004almost 21 years ago
The Seventh Annual International Employment Surveyalmost 21 years ago
Pharmaco-FakeryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
4
2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development
5
